References
Yang J, Li P, Piao Y, et al. CD56-negative extranodal natural killer/T-cell lymphoma: a retrospective study in 443 patients treated by chemotherapy with or without asparaginase. Front Immunol 2022; 13: 829366.
Yamazaki M, Kakuta M, Takimoto R, Murayama N, Takamori K. Nasal natural killer cell lymphoma presenting as lethal midline granuloma. Int J Dermatol 2000; 39: 931–4.
Kim HI, Kim SH, Oh SH. CD56-negative extranodal NK/T-cell lymphoma, nasal type, with extranasal cutaneous involvement. Ann Dermatol 2015; 27: 618–20.
Chan JK, Sin VC, Wong KF, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–13.
Wang W, Nong L, Liang L, et al. Extranodal NK/T-cell lymphoma, nasal type without evidence of EBV infection. Oncol Lett 2020; 20: 2665–76.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest none.
About this article
Cite this article
Kobayashi, A., Goto, H., Negishi-Asano, A. et al. Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56. Eur J Dermatol 33, 705–706 (2023). https://doi.org/10.1684/ejd.2023.4583
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2023.4583